Alex Blyth's Interview about how LIfT came to be, and why we need to move on from mouse models
The Business of Biotech interviews serial inventor and entrepreneur Alex Blyth who had long held interests in health and science, but...
top of page
LATEST NEWS
- Oct 21, 2022
LIfT at The Rejuvenation Summit
LIfT BioSciences presented at Forever Healthy Foundation's Rejuvenation Summit In Berlin. Alex Blyth, LIfT's CEO, presented on the links...
- Sep 13, 2022
N-LIfT shows potent cancer killing across multiple solid tumour types
LIfT BioSciences announces its N-LIfT cell therapy shows tumour destruction across five different solid tumour types in PDX tumouroid...
bottom of page